Trial Profile
Efficacy of valganciclovir prophylaxis to prevent cytomegalovirus infections in patients with kidney transplant
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Oct 2016
Price :
$35
*
At a glance
- Drugs Valganciclovir (Primary)
- Indications Cytomegalovirus infections
- Focus Therapeutic Use
- 07 Oct 2016 New trial record